Skin bioprinting: the future of burn wound reconstruction?
Bioprinting
Burns
Reconstruction
Skin
Journal
Burns & trauma
ISSN: 2321-3868
Titre abrégé: Burns Trauma
Pays: England
ID NLM: 101651457
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
08
2018
accepted:
08
01
2019
entrez:
27
2
2019
pubmed:
26
2
2019
medline:
26
2
2019
Statut:
epublish
Résumé
Burns are a significant cause of trauma, and over the years, the focus of patient care has shifted from just survival to facilitation of improved functional outcomes. Typically, burn treatment, especially in the case of extensive burn injuries, involves surgical excision of injured skin and reconstruction of the burn injury with the aid of skin substitutes. Conventional skin substitutes do not contain all skin cell types and do not facilitate recapitulation of native skin physiology. Three-dimensional (3D) bioprinting for reconstruction of burn injuries involves layer-by-layer deposition of cells along with scaffolding materials over the injured areas. Skin bioprinting can be done either in situ or in vitro. Both these approaches are similar except for the site of printing and tissue maturation. There are technological and regulatory challenges that need to be overcome for clinical translation of bioprinted skin for burn reconstruction. However, the use of bioprinting for skin reconstruction following burns is promising; bioprinting will enable accurate placement of cell types and precise and reproducible fabrication of constructs to replace the injured or damaged sites. Overall, 3D bioprinting is a very transformative technology, and its use for wound reconstruction will lead to a paradigm shift in patient outcomes. In this review, we aim to introduce bioprinting, the different stages involved, in vitro and in vivo skin bioprinting, and the various clinical and regulatory challenges in adoption of this technology.
Identifiants
pubmed: 30805375
doi: 10.1186/s41038-019-0142-7
pii: 142
pmc: PMC6371568
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
4Déclaration de conflit d'intérêts
Not applicableNot applicableThe authors declare that they have no competing interests.
Références
J Biomech Eng. 2013 Sep;135(9):91011
pubmed: 23719889
SLAS Technol. 2017 Aug;22(4):447-453
pubmed: 27325107
J Med Ethics. 2005 Jan;31(1):2-6
pubmed: 15634745
Skin Pharmacol Physiol. 2009;22(2):94-102
pubmed: 19188757
J Lab Autom. 2016 Aug;21(4):496-509
pubmed: 25609254
Burns. 2010 May;36(3):305-21
pubmed: 19897310
Adv Skin Wound Care. 2007 Sep;20(9 Pt 1):493-508; quiz 509-10
pubmed: 17762218
Ann Surg. 1988 Sep;208(3):313-20
pubmed: 3048216
Burns. 2008 Feb;34(1):93-7
pubmed: 17644263
Biotechnol Bioeng. 2012 Jul;109(7):1855-63
pubmed: 22328297
Nature. 2007 Feb 22;445(7130):874-80
pubmed: 17314974
Biofabrication. 2016 Dec 05;9(1):015006
pubmed: 27917823
Burns. 1994;20 Suppl 1:S39-42
pubmed: 8198741
Burns. 2008 Mar;34(2):153-63
pubmed: 18226455
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3179-84
pubmed: 26951646
J Funct Biomater. 2015 Jul 09;6(3):547-63
pubmed: 26184327
Plast Reconstr Surg. 1993 Aug;92(2):260-70
pubmed: 8337276
Br J Plast Surg. 2001 Dec;54(8):659-64
pubmed: 11728107
Crit Rev Biochem Mol Biol. 1992;27(1-2):93-127
pubmed: 1309319
Sci Rep. 2016 Oct 03;6:34410
pubmed: 27694985
Crit Care Med. 2007 Nov;35(11):2615-23
pubmed: 17828040
Appl Microbiol Biotechnol. 2013 May;97(10):4243-58
pubmed: 23525900
Nanomedicine (Lond). 2010 Apr;5(3):507-15
pubmed: 20394540
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
Lab Chip. 2014 Jan 21;14(2):268-75
pubmed: 24257507
Trends Biotechnol. 2015 Jul;33(7):395-400
pubmed: 25978871
Surg Clin North Am. 2014 Aug;94(4):909-16
pubmed: 25085096
J Burn Care Rehabil. 1992 Sep-Oct;13(5):519-29
pubmed: 1452585
J Mater Chem B. 2015 May 28;3(20):4105-4117
pubmed: 32262288
Acta Chir Plast. 1996;38(4):142-6
pubmed: 9037792
Curr Opin Biotechnol. 2016 Aug;40:103-112
pubmed: 27043763
Adv Mater. 2014 May 21;26(19):3124-30
pubmed: 24550124
Exp Dermatol. 2018 May;27(5):453-459
pubmed: 28453913
Tissue Eng Part C Methods. 2010 Oct;16(5):847-54
pubmed: 19883209
Trends Biotechnol. 2016 Sep;34(9):700-710
pubmed: 27113634
Biofabrication. 2012 Jun;4(2):022001
pubmed: 22406433
Plast Reconstr Surg. 2017 Jan;139(1):120e-138e
pubmed: 28027250
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Burns. 2014 Dec;40(8):1727-37
pubmed: 24746282
Burns. 2003 Dec;29(8):837-41
pubmed: 14636761
Adv Healthc Mater. 2017 Feb;6(4):
pubmed: 27976537
J Trauma. 1981 Jun;21(6):433-8
pubmed: 7230295
N Engl J Med. 2009 Feb 26;360(9):893-901
pubmed: 19246361
Burns. 2016 Nov;42(7):1471-1476
pubmed: 27520711
Br J Plast Surg. 1978 Jan;31(1):3-8
pubmed: 342028
Burns. 2001 Feb;27(1):61-6
pubmed: 11164667
Adv Drug Deliv Rev. 2018 Jan 1;123:155-164
pubmed: 29079536
Burns. 2011 Nov;37(7):1222-8
pubmed: 21726949
Biomaterials. 2009 Apr;30(12):2164-74
pubmed: 19176247
Burns. 1994 Feb;20(1):61-4
pubmed: 8148080
Annu Rev Biomed Eng. 2013;15:177-200
pubmed: 23642245
Tissue Eng Part C Methods. 2011 Jan;17(1):79-87
pubmed: 20673023
Biomaterials. 2014 Dec;35(36):9591-8
pubmed: 25176070
Plast Reconstr Surg Glob Open. 2016 Jun 10;4(6):e731
pubmed: 27482479
Burns. 1993 Apr;19(2):142-5
pubmed: 8471149
Crit Care. 2013 Oct 07;17(5):241
pubmed: 24093225
Biofabrication. 2009 Sep;1(3):035002
pubmed: 20811106
Stem Cells Transl Med. 2012 Nov;1(11):792-802
pubmed: 23197691
Surg Radiol Anat. 2011 Dec;33(10):835-42
pubmed: 21212951
Ann R Coll Surg Engl. 2017 Jul;99(6):432-438
pubmed: 28560888
Burns. 2002 Dec;28(8):752-9
pubmed: 12464473
Burns. 2015 Dec;41(8):1660-1663
pubmed: 26233898
Burns. 2010 Jun;36(4):450-60
pubmed: 20022702
Biomaterials. 2009 Mar;30(8):1587-95
pubmed: 19108884
Adv Healthc Mater. 2016 Nov;5(22):2856-2865
pubmed: 27767258
PLoS One. 2013;8(3):e57741
pubmed: 23469227
Biofabrication. 2018 May 11;10(3):034101
pubmed: 29693552
Biofabrication. 2011 Sep;3(3):034113
pubmed: 21900730
Burns. 2012 Nov;38(7):998-1004
pubmed: 22694874
Curr Pharm Biotechnol. 2013;14(1):91-7
pubmed: 23570054
Plast Reconstr Surg. 2011 May;127(5):1958-1966
pubmed: 21228739
Adv Skin Wound Care. 2001 Jan-Feb;14(1):37-44; quiz 45-6
pubmed: 11905455
Acta Biomater. 2016 Mar 01;32:170-177
pubmed: 26747979
Burns. 2006 Mar;32(2):145-50
pubmed: 16414197
Drug Discov Today. 2019 Jan;24(1):198-205
pubmed: 30244080
Clin Dermatol. 2005 Jul-Aug;23(4):403-12
pubmed: 16023936
Biofabrication. 2016 Mar 01;8(1):014103
pubmed: 26930133
Nat Mater. 2012 Sep;11(9):768-74
pubmed: 22751181
Indian J Plast Surg. 2010 Sep;43(Suppl):S23-8
pubmed: 21321652
Biofabrication. 2018 Jan 23;10(2):025005
pubmed: 29360631
Burns. 2010 Feb;36(1):23-8
pubmed: 19864070
Plast Reconstr Surg. 2017 Jan;139(1):212-219
pubmed: 27632398
Tissue Eng Part A. 2008 Jan;14(1):41-8
pubmed: 18333803
Biofabrication. 2010 Jun;2(2):022001
pubmed: 20811127
Dev Dyn. 2015 May;244(5):629-40
pubmed: 25613150
Stem Cells Transl Med. 2015 Feb;4(2):130-5
pubmed: 25575525
Burns. 2011 Nov;37(7):1087-100
pubmed: 21802856
Adv Drug Deliv Rev. 2018 Jan 1;123:3-17
pubmed: 28941987
Biomater Res. 2018 Apr 06;22:11
pubmed: 29636985
Plast Reconstr Surg. 1987 Aug;80(2):248-54
pubmed: 3602174
Tissue Eng Part B Rev. 2009 Dec;15(4):455-65
pubmed: 19552605
Tissue Eng Part C Methods. 2011 Mar;17(3):289-98
pubmed: 20849381
Biofabrication. 2010 Mar;2(1):014101
pubmed: 20811116
Burns. 2017 Mar;43(2):290-296
pubmed: 28029474
Acta Chir Plast. 2017 Summer;59(1):11-17
pubmed: 28869381